Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase II clinical trial on Gensia's second-generation adenosine-regulating agent commence

May 31, 1996

Gene transfer as treatment for myocardial ischemia

May 31, 1996

Valsartan approved in Germany

May 31, 1996

Endothelin antagonists revealed by Fujisawa

May 31, 1996

Sanofi Winthrop research reveals elastase inhibitors

May 31, 1996

Small-molecule alpha4 integrin antagonists generation disclosed by Biogen

May 31, 1996

Nikken Chemicals reports antiallergic/antiinflammatory N-hydroxyureas

May 31, 1996

Medeva owns U.S. rights to acrivastine/pseudoephedrine HCI

May 31, 1996

FDA approval for RPR's new triamcinolone acetonide formulation

May 31, 1996

Hyaluronic acid and derivatives described by Hyal

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...